Pharma Sciences Site Head (Non-Clinical), Roche Innovation Center Copenhagen
Since October 2014
Director, then Senior Director Non-Clinical R&D
April 2011 --- September 2014
Santaris Pharma A/S, a privately held clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, is delivering on the promise of RNA-targeted medicines, today. The Locked Nucleic Acid (LNA) Drug Platform and Drug Discovery Engine developed by Santaris Pharma A/S combine the Company’s proprietary LNA chemistry with its highly specialized and targeted drug development capabilities to rapidly deliver potent single-stranded LNA-based drug candidates across a multitude of disease states. Santaris Pharma A/S internal research and development activities currently focus on infectious diseases and metabolic disorders while partnerships with major pharmaceutical companies cover a range of therapeutic areas including cancer, cardiovascular disease, infectious and inflammatory diseases, and rare genetic disorders.
Director Toxicology & Pathology
January 2008 --- April 2011
Aptuit is a global service company helping pharmaceutical and biotechnology clients to develop their drug candidates, from synthesis to the clinic. I was heading-up the toxicology department in Edinburgh, UK.
Director, Comparative Medicine
July 2004 --- December 2007
Started as a Study Director and Project Toxicologist then moved over to a Lab Animal Medicine Management role.
Head of Biotechnical Group/Study Director
March 2000 --- June 2004
Operational management of the technical teams in General Toxicology, Reproduction Toxicology and Safety Pharmacology (23 colleagues). Clinical veterinarian. General toxicology Study Director
Clinical Research Associate (Veterinary)
October 1996 --- February 2000
Conducted veterinary clinical trials on behaviour modification substances.
Critical thinkingDependabilityFlexibilityIndependenceOrganizationPerspectiveResponsibilityProblem solvingService orientedSelf-disciplineResult Oriented
Skills and Expertise
project managementdrug developmentnon-clinical safetyophthalmologycardiologytranslational medicineCRO operational managementoligonucleotide
Certificate in Translational Medicine from The University of Edinburgh in 2011
Cert Vet Ophthalm. (CESOV) in Veterinary Ophthalmology from Ecole nationale vétérinaire de Toulouse in 2002
MPhil (DEA) in Environmental Toxicology from Aix-Marseille Université in 1999
DVM in Veterinary Medicine from Ecole nationale vétérinaire d'Alfort in 1996
Training and Certification
European Registered Toxicologist Certification